Kindeva Drug Delivery is a leading global drug-device combination CDMO specializing in sterile injectables, pulmonary and nasal inhalation, and dermal/transdermal drug delivery platforms. The company has a history spanning back to 1956 when it invented the pressurized metered-dose inhaler (pMDI). Kindeva operates a global network of 10 manufacturing and R&D sites including a 155,000+ sq ft dedicated aseptic operations facility in Bridgeton. They hold 12 FDA-approved products across aerosol, metered-dose, film, and extended release dosage forms. Their FDA record shows 38 inspections (9 NAI, 22 VAI, 7 OAI) and 6 FEI-registered facilities covering analysis, manufacture, and sterilization.
sterile injectables, metered-dose inhalers (MDI), dry powder inhalers, nasal drug delivery, transdermal patches, autoinjectors (ComboPen, TruJect, BinaJect), aseptic fill-finish, drug-device combinations, low-GWP propellant inhalers
2 sites worldwide
No reviews available yet.
No documents available.